The United Nations Office on Drugs and Crime (UNODC) has issued a global handbook to help practitioners minimize the diversion of pharmaceuticals containing controlled substances from the regulated supply chain."Diversion" involves the illegal movement of these medicines — often through theft, fraudulent prescriptions, or the falsification of business records — into unauthorised markets, which leads to public health risks and reduced availability for legitimate patients.
The framework advocates for a "Prevent, Detect, Respond" model, emphasizing proactive data analysis, regulatory inspections, and multi-agency coordination between law enforcement and health authorities. By balancing strict control measures with the medical necessity of access to these substances, the UNODC seeks to secure the global supply chain against increasingly sophisticated pharmaceutical crimes, including the rise of falsified medicines containing dangerous synthetic opioids.
Key Pillars of the Diversion Prevention Model
"Prevent, Detect, Respond" Framework: Implementing a proactive cycle of monitoring, identifying suspicious virtual/physical indicators, and executing multi-agency investigations.
Good Distribution Practices (GSDP): Enforcing rigorous licensing and due diligence standards for third-party supply chain actors to ensure legitimacy.
Operational Risk Assessment: Utilizing systematic templates to evaluate vulnerabilities, such as weaknesses in wholesale licensing systems exploited by criminals.
Secure Disposal Protocols: Establishing strict procedures for the destruction of unused or expired controlled medicines to prevent "waste-stream" diversion.
Online Vigilance: Monitoring illegal sales and advertisements on digital platforms to detect the unauthorized supply of controlled substances.
International Reporting Compliance: Aligning national inspections and data collection with INCB reporting requirements to maintain global supply chain transparency.
What is "Diversion"? Diversion is the unsanctioned movement of controlled medicines from the regulated, legal supply chain to illegal markets or unauthorized users. It operates through various mechanical failures in the system, such as excessive purchasing by licensed wholesalers, the theft of physical stock, or "patient diversion" where legitimate prescriptions are resold. Identifying diversion is a prerequisite for ensuring that essential medicines—like potent analgesics or psychiatric drugs—remain available for patients in pain or need, rather than fueling addiction and pharmaceutical crime in the underground economy.
Policy Relevance: India’s Controlled Substance Regulation
Operationalising Central Drugs Standard Control Organization (CDSCO) Inspections: The UNODC’s GSDP recommendations act as a primary mechanic for the CDSCO to refine its risk-based inspection models for pharmaceutical warehouses and distributors.
Internalizing Data-Driven Monitoring: Implementing proactive data analysis on prescription patterns provides a functional framework for the Narcotics Control Bureau (NCB) to identify regional "hotspots" of pharmaceutical leakage.
Bypassing Falsified Medicine Risks: The focus on addressing "pharmaceutical crime" acts as a shield against the infiltration of synthetic opioids into the Indian market, which often appear as falsified versions of controlled medicines.
Link to Global Compliance: Adopting the UNODC's operational risk assessment templates is a prerequisite for India to enhance its standing and data accuracy within the INCB reporting framework.
Follow the Full Release Here: UNODC Handbook: Preventing the Diversion of Controlled Pharmaceuticals
